镉毒性相关代谢性骨病:五例临床难题
五名印度金匠因首饰制作吸入镉烟尘,出现从骨量减少到严重骨质疏松和骨折的骨骼表现,并伴肾小管功能障碍。镉的直接骨毒性、肾小管损伤和FGF23过多所致低磷血症及继发性甲状旁腺功能亢进共同参与发病,补充钙、磷、维生素D类似物及支持治疗可稳定骨健康。
要点
- 首饰制作中吸入镉烟尘是印度被低估的职业危害,可导致骨质疏松、骨折和肾功能障碍。
- 镉毒性相关骨病表现多样:例1为近端肾小管酸中毒、低磷性骨软化、继发性甲旁亢和进行性皮质骨丢失。
- 低尿酸血症是早期肾小管损伤的敏感生物标志物,职业史结合简单生物标志物有助于早期识别。
核心结论
- 金匠长期职业性镉暴露通过直接骨毒性、肾小管功能障碍和FGF23过多所致低磷血症及继发性甲状旁腺功能亢进引起多样的骨骼表现。
- 镉的毒性作用优先累及松质骨,而肾脏介导的机制参与皮质骨丢失。
- 通过职业史和血清尿酸等简单生物标志物早期识别,对预防不可逆并发症至关重要。
- 补充钙、磷、维生素D类似物及支持治疗可稳定骨健康并改善结局。
研究设计与样本
- 对五名在首饰制作中职业性暴露于镉的患者进行临床评估。
- 评估包括详细临床病史、生化检查(肾脏和代谢指标、骨转换标志物、完整成纤维细胞生长因子23水平)、双能X线吸收测定法(DXA)以及电感耦合等离子体质谱法测定镉。
- 肾小管功能通过尿β2-微球蛋白和血清尿酸评估。
主要发现
- 全部五名患者均存在骨骼受累,范围从骨量减少到严重骨质疏松和骨折。
- 例1有近端肾小管酸中毒、低磷性骨软化、继发性甲状旁腺功能亢进和进行性皮质骨丢失,补充治疗后临床改善。
- 例2表现为近端肌病、骨质疏松和心肌病,伴肾性磷酸盐尿。
- 例3至例5主要表现为松质骨丢失,伴不同程度的肾小管功能障碍和显著升高的镉水平。
- 低磷血症由肾小管损伤和FGF23依赖机制共同介导,低尿酸血症是早期肾小管损伤的敏感生物标志物。
临床怎么用
- 通过职业史识别镉暴露,并借助血清尿酸等简单生物标志物早期发现肾小管损伤。
- 补充钙、磷、维生素D类似物及支持治疗可稳定骨健康并改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Cadmium exposure from jewellery-making fumes can damage bones and kidneys. In five goldsmiths, we found osteoporosis, fractures, and renal dysfunction linked to high cadmium levels. Both direct toxicity and indirect effects through kidney damage and hormones contributed. Awareness and early detection may prevent irreversible complications. INTRODUCTION: Cadmium (Cd) is a highly toxic heavy metal with established skeletal and renal toxicity. Inhalation of Cd fumes during jewellery-making is an underrecognized occupational hazard in India. We report five goldsmiths with chronic Cd exposure who developed varying patterns of metabolic bone disease, aiming to highlight the diverse mechanisms of Cd-induced osteopathy. METHODS: Five patients with occupational exposure to Cd in jewellery-making were evaluated through detailed clinical history, biochemical investigations (renal and metabolic profile, bone turnover markers, intact fibroblast growth factor 23 levels), dual-energy X-ray absorptiometry (DXA), and Cd measurement by inductively coupled plasma mass spectrometry. Renal tubular function was assessed with urinary β2-microglobulin and serum uric acid. RESULTS: All five patients exhibited skeletal involvement, ranging from osteopenia to severe osteoporosis and fractures. Case 1 had proximal renal tubular acidosis, hypophosphatemic osteomalacia, secondary hyperparathyroidism, and progressive cortical bone loss, with clinical improvement after supplementation therapy. Case 2 showed proximal myopathy, osteoporosis, and cardiomyopathy, with renal phosphaturia. Cases 3-5 demonstrated primarily cancellous bone loss with variable renal tubular dysfunction and markedly elevated Cd levels. Hypophosphatemia was mediated by both tubular damage and FGF23-dependent mechanisms. Hypouricemia emerged as a sensitive biomarker of early tubular injury. CONCLUSIONS: Chronic occupational Cd exposure in goldsmiths causes diverse skeletal manifestations through direct osteotoxicity, hypophosphatemia from renal tubular dysfunction and FGF23 excess, and secondary hyperparathyroidism. The toxic effect preferentially involves cancellous bone, while renal-mediated mechanisms contribute to cortical bone loss. Early recognition via occupational history, supported by simple biomarkers such as serum uric acid, is essential to prevent irreversible complications. Supplementation with calcium, phosphate, vitamin D analogues, and supportive therapy can stabilize bone health and improve outcomes.
引用
- Giri S, Roy A, Kumar A, et al. Cadmium toxicity-related metabolic bone disease: a clinical conundrum of five cases. Osteoporos Int. 2025. PMID: 41413240. doi:10.1007/s00198-025-07810-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。